These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2368297)

  • 1. Effectiveness of three antiviral agents against FIP virus in vitro.
    Barlough JE; Scott FW
    Vet Rec; 1990 Jun; 126(22):556-8. PubMed ID: 2368297
    [No Abstract]   [Full Text] [Related]  

  • 2. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.
    Jordan I; Briese T; Fischer N; Lau JY; Lipkin WI
    J Infect Dis; 2000 Oct; 182(4):1214-7. PubMed ID: 10979920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
    Leyssen P; De Clercq E; Neyts J
    Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of ribavirin against canine distemper virus.
    Elia G; Belloli C; Cirone F; Lucente MS; Caruso M; Martella V; Decaro N; Buonavoglia C; Ormas P
    Antiviral Res; 2008 Feb; 77(2):108-13. PubMed ID: 17949825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Error-prone replication of West Nile virus caused by ribavirin.
    Day CW; Smee DF; Julander JG; Yamshchikov VF; Sidwell RW; Morrey JD
    Antiviral Res; 2005 Jul; 67(1):38-45. PubMed ID: 15919121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ribavirin--pharmacological features, antiviral effects against hepatitis C virus (HCV) and other viruses and side effects during treatment].
    Wawrzynowicz-Syczewska M
    Przegl Epidemiol; 2002; 56 Suppl 5():35-40. PubMed ID: 15553070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to antiviral chemotherapy: a status report.
    O'Connor TE
    Adv Pathobiol; 1976; (5):151-8. PubMed ID: 1053033
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications of finding synergic in vitro drug-drug interactions between interferon-alpha and ribavirin for the treatment of hepatitis C virus.
    Buckwold VE
    J Antimicrob Chemother; 2004 Mar; 53(3):413-4. PubMed ID: 14963071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin inhibits Borna disease virus proliferation and fatal neurological diseases in neonatally infected gerbils.
    Lee BJ; Matsunaga H; Ikuta K; Tomonaga K
    Antiviral Res; 2008 Dec; 80(3):380-4. PubMed ID: 18778737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral agents].
    Amato Neto V; Barone AA
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Oct; 36(5):221-9. PubMed ID: 6176002
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo studies of ribavirin action on Brazilian Orthobunyavirus.
    Livonesi MC; De Sousa RL; Badra SJ; Figueiredo LT
    Am J Trop Med Hyg; 2006 Nov; 75(5):1011-6. PubMed ID: 17124004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
    Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
    Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
    J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro.
    Acosta EG; Bruttomesso AC; Bisceglia JA; Wachsman MB; Galagovsky LR; Castilla V
    Virus Res; 2008 Aug; 135(2):203-12. PubMed ID: 18462821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus.
    Cuevas JM; Sanjuán R; Moya A; Elena SF
    Infect Genet Evol; 2005 Jan; 5(1):55-65. PubMed ID: 15567139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiviral effects of an effective section of a prescription of traditional Chinese medicine on influenza virus A in vitro].
    Huang SH; Feng XL; Zhang LL; Xu SP; Wu CY; Wei W
    Zhong Yao Cai; 2009 Mar; 32(3):391-4. PubMed ID: 19565719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral and anticellular effects of synthetic (2'-5')-oligoadenylate (A 2' p 5' A 2' p 5' A) in Rauscher murine leukaemia.
    Kára J; Mach O; Smrt J
    Acta Virol; 1983 Nov; 27(6):477-83. PubMed ID: 6140832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of ribavirin on Junin virus replication in vitro.
    Rodríguez M; McCormick JB; Weissenbacher MC
    Rev Argent Microbiol; 1986; 18(2):69-74. PubMed ID: 2825242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanobacteria a potential source of antiviral substances against influenza virus.
    Zainuddin EN; Mundt S; Wegner U; Mentel R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):181-2. PubMed ID: 12458356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.